Published in Prev Med on December 18, 2006
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations | NCT01156610
Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev (2008) 1.87
Adolescents' impressions of antismoking media literacy education: qualitative results from a randomized controlled trial. Health Educ Res (2008) 1.30
Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res (2011) 1.10
Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers. J Natl Med Assoc (2012) 1.08
Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open (2014) 1.07
Development of a culturally targeted smoking cessation intervention for African American smokers. J Community Health (2009) 0.98
Smoking abstinence-related expectancies among American Indians, African Americans, and women: potential mechanisms of tobacco-related disparities. Psychol Addict Behav (2013) 0.93
Barriers to effective tobacco-dependence treatment for the very poor. J Stud Alcohol Drugs (2012) 0.92
Smoking and prostate cancer in a multi-ethnic cohort. Prostate (2013) 0.87
Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States. Z Gesundh Wiss (2009) 0.87
Population-based tobacco treatment: study design of a randomized controlled trial. BMC Public Health (2012) 0.86
Why do smokers try to quit without medication or counselling? A qualitative study with ex-smokers. BMJ Open (2015) 0.85
Place of birth,age of immigration,and disability in Hispanics with multiple sclerosis. Mult Scler Relat Disord (2015) 0.85
Disparities between blacks and whites in tobacco and lung cancer treatment. Oncologist (2011) 0.83
Understanding and use of nicotine replacement therapy and nonpharmacologic smoking cessation strategies among Chinese and Vietnamese smokers and their families. Prev Chronic Dis (2014) 0.83
Preliminary findings on the association between clients' perceived helpfulness of substance abuse treatment and outcomes: does race matter? Drug Alcohol Depend (2014) 0.82
A Social Network Family-Focused Intervention to Promote Smoking Cessation in Chinese and Vietnamese American Male Smokers: A Feasibility Study. Nicotine Tob Res (2015) 0.82
Proactive tobacco treatment for low income smokers: study protocol of a randomized controlled trial. BMC Public Health (2014) 0.81
Changing low income smokers' beliefs about tobacco dependence treatment. Subst Use Misuse (2014) 0.81
Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatment. Per Med (2013) 0.80
Factors associated with discontinuation of bupropion and counseling among African American light smokers in a randomized clinical trial. Ann Behav Med (2013) 0.80
Black and White adults' perspectives on the genetics of nicotine addiction susceptibility. Addict Behav (2011) 0.80
Barriers to Telephone Quitline Use Among Methadone-Maintained Smokers. Nicotine Tob Res (2015) 0.80
Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey. BMJ Open (2015) 0.79
Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy. Nicotine Tob Res (2014) 0.79
Feasibility and effectiveness of a community-based smoking cessation intervention in a racially diverse, urban smoker cohort. Am J Public Health (2014) 0.77
African American smokers' intention to use pharmacotherapy for cessation. Am J Health Behav (2012) 0.77
Utilization of smoking cessation medication benefits among medicaid fee-for-service enrollees 1999-2008. PLoS One (2017) 0.75
Perceptions of E-Cigarettes among Black Youth in California. Int J Environ Res Public Health (2017) 0.75
Understanding socio-cultural influences on smoking among older Greek-Australian smokers aged 50 and over: facilitators or barriers? A qualitative study. Int J Environ Res Public Health (2015) 0.75
Physician Advice to Adolescents About Smoking: Who Gets Advised and Who Benefits Most? J Adolesc Health (2016) 0.75
Social Environmental Influences on Smoking and Cessation: Qualitative Perspectives Among Chinese-Speaking Smokers and Nonsmokers in California. J Immigr Minor Health (2016) 0.75
Speaking out about physical harms from tobacco use: response to graphic warning labels among American Indian/Alaska Native communities. BMJ Open (2016) 0.75
Latino Adults' Perspectives on Treating Tobacco Use Via Social Media. JMIR Mhealth Uhealth (2017) 0.75
Impact of large-scale distribution and subsequent use of free nicotine patches on primary care physician interaction. BMC Public Health (2017) 0.75
MS in self-identified Hispanic/Latino individuals living in the US. Mult Scler J Exp Transl Clin (2017) 0.75
Attitudes Toward Mental Health Services Among American Indians by Two Age Groups. Community Ment Health J (2015) 0.75
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Randomized Trial of Reduced-Nicotine Standards for Cigarettes. N Engl J Med (2015) 3.63
Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control (2006) 3.49
Do Contact and Empathy Mitigate Bias Against Gay and Lesbian People Among Heterosexual First-Year Medical Students? A Report From the Medical Student CHANGE Study. Acad Med (2015) 2.74
Reducing racial bias among health care providers: lessons from social-cognitive psychology. J Gen Intern Med (2007) 2.49
Why do providers contribute to disparities and what can be done about it? J Gen Intern Med (2004) 2.25
Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol (2006) 2.17
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med (2006) 2.12
Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res (2007) 2.02
Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst (2004) 1.99
National trends in the provision of smoking cessation aids within the Veterans Health Administration. Am J Manag Care (2005) 1.94
Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol (2009) 1.89
Physicians' perceptions of patients' social and behavioral characteristics and race disparities in treatment recommendations for men with coronary artery disease. Am J Public Health (2005) 1.89
Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev (2008) 1.87
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol (2010) 1.84
Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol Biomarkers Prev (2009) 1.82
Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol Biomarkers Prev (2005) 1.77
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev (2005) 1.76
Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.74
The association between perceived discrimination and underutilization of needed medical and mental health care in a multi-ethnic community sample. J Health Care Poor Underserved (2008) 1.72
Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev (2008) 1.72
Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA (2010) 1.71
Implicit and explicit weight bias in a national sample of 4,732 medical students: the medical student CHANGES study. Obesity (Silver Spring) (2014) 1.71
Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev (2007) 1.66
Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence-based tobacco cessation treatments. Addiction (2010) 1.62
Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial. J Am Coll Cardiol (2010) 1.59
Does stereotype threat affect women in academic medicine? Acad Med (2012) 1.57
Understanding the provider contribution to race/ethnicity disparities in pain treatment: insights from dual process models of stereotyping. Pain Med (2006) 1.55
Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem Res Toxicol (2007) 1.49
Stereotype threat and health disparities: what medical educators and future physicians need to know. J Gen Intern Med (2010) 1.45
Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND). Nicotine Tob Res (2008) 1.42
Why assigning ongoing tobacco use is not necessarily a conservative approach to handling missing tobacco cessation outcomes. Nicotine Tob Res (2009) 1.42
Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promot (2005) 1.38
Reduced nicotine content cigarettes and nicotine patch. Cancer Epidemiol Biomarkers Prev (2013) 1.37
Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine Tob Res (2006) 1.36
Effects of progesterone treatment on smoked cocaine response in women. Pharmacol Biochem Behav (2002) 1.34
Menthol cigarettes and smoking cessation during an aided quit attempt. Nicotine Tob Res (2008) 1.34
Patient race and physicians' decisions to prescribe opioids for chronic low back pain. Soc Sci Med (2008) 1.30
Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge. Tob Control (2007) 1.30
Economic burden for informal caregivers of lung and colorectal cancer patients. Oncologist (2010) 1.30
Race, socioeconomic status, and the perceived importance of positive self-presentation in health care. Soc Sci Med (2005) 1.27
Effective tobacco dependence treatment. JAMA (2002) 1.25
Smokers' relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J Vasc Surg (2003) 1.25
Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example. Cancer Epidemiol Biomarkers Prev (2009) 1.24
Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine. Nicotine Tob Res (2007) 1.23
Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med (2010) 1.23
Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype. J Pharmacol Exp Ther (2009) 1.22
A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiol Biomarkers Prev (2004) 1.21
Inhibition of CYP2D6 activity by bupropion. J Clin Psychopharmacol (2005) 1.19
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. Cancer Epidemiol Biomarkers Prev (2008) 1.18
Perceived risk of harm from cigarettes or smokeless tobacco among U.S. high school seniors. Nicotine Tob Res (2007) 1.18
Promoting repeat tobacco dependence treatment: are relapsed smokers interested? Am J Manag Care (2006) 1.17
Effects of perceived discrimination on mental health and mental health services utilization among gay, lesbian, bisexual and transgender persons. J LGBT Health Res (2007) 1.17
Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. Chem Res Toxicol (2007) 1.16
Developing the science base for reducing tobacco harm. Nicotine Tob Res (2007) 1.15
Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol Biomarkers Prev (2006) 1.15
Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods. Cancer Epidemiol Biomarkers Prev (2009) 1.13
The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex. Cancer Epidemiol Biomarkers Prev (2013) 1.13
Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch. Nicotine Tob Res (2011) 1.12
Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers. Cancer Epidemiol Biomarkers Prev (2010) 1.11
The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics. Cancer Epidemiol Biomarkers Prev (2007) 1.10
Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial. Nicotine Tob Res (2008) 1.09
Randomized trial of an intervention to facilitate recycling for relapsed smokers. Am J Prev Med (2006) 1.09
Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res (2002) 1.09
Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers. Nat Rev Cancer (2009) 1.09
Conference on abuse liability and appeal of tobacco products: conclusions and recommendations. Drug Alcohol Depend (2011) 1.09
Access to nicotine replacement therapy as part of a statewide tobacco telephone helpline. Am J Health Promot (2006) 1.08
Efficacy of nicotine patch in smokers with a history of alcoholism. Alcohol Clin Exp Res (2003) 1.07
Effects of gender and depressive symptoms on quality of life among colorectal and lung cancer patients and their family caregivers. Psychooncology (2014) 1.06
The effect of perceived racial discrimination on bodily pain among older African American men. Pain Med (2009) 1.06
Assessing the institutional approach to implementing smoking cessation practice guidelines in veterans health administration facilities. Mil Med (2006) 1.04
Variation in estimates of limited health literacy by assessment instruments and non-response bias. J Gen Intern Med (2010) 1.04
Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res (2007) 1.03
Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. Cancer Epidemiol Biomarkers Prev (2008) 1.02
Unhealthy interactions: the role of stereotype threat in health disparities. Am J Public Health (2012) 1.02
Racial disparities in VA service connection for posttraumatic stress disorder disability. Med Care (2003) 1.02
Beliefs and experiences regarding smoking cessation among American Indians. Nicotine Tob Res (2007) 1.01
Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation. Carcinogenesis (2012) 1.01
Flavored and nonflavored smokeless tobacco products: rate, pattern of use, and effects. Nicotine Tob Res (2012) 1.01
CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. Pharmacogenet Genomics (2012) 1.00
Provider recommendations for colorectal cancer screening in elderly veterans. J Gen Intern Med (2009) 1.00
Families of patients with polytrauma: Understanding the evidence and charting a new research agenda. J Rehabil Res Dev (2009) 0.99
Exploring unconscious bias in disparities research and medical education. JAMA (2011) 0.99
Are gender differences in colorectal cancer screening rates due to differences in self-reporting? Prev Med (2009) 0.99
Improving endoscopy completion: effectiveness of an interactive voice response system. Am J Manag Care (2011) 0.99
Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry. Tob Control (2011) 0.99
Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. Drug Alcohol Depend (2003) 0.98
Potential unintended consequences of tobacco-control policies on mothers who smoke: a review of the literature. Am J Prev Med (2009) 0.97
Employment, gender, and smoking cessation outcomes in low-income smokers using nicotine replacement therapy. Nicotine Tob Res (2009) 0.97